The efficacy and safety of anlotinib combined with platinum-etoposide chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A Chinese multicenter real-world study

The efficacy and safety of anlotinib combined with platinum-etoposide chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A Chinese multicenter real-world study

BackgroundPatients with extensive-stage small-cell lung cancer (ES-SCLC) have high recurrence rates and bleak prognosis. This multicenter real-world study aimed to explore the efficacy and safety of anlotinib combined with platinum-etoposide chemotherapy as the first-line treatment of ES-SCLC.Method...

Full description

Bibliographic Details
Main Authors: Hao-Ran Zheng, Ai-Min Jiang, Huan Gao, Na Liu, Xiao-Qiang Zheng, Xiao Fu, Zhi-Ping Ruan, Tao Tian, Xuan Liang, Yu Yao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Oncology
Subjects:
small cell lung cancer
anlotinib
chemotherapy
real-world data
efficacy
safety
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.894835/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.894835/full

Similar Items